New botulinum neurotoxin constructs for treatment of chronic pain. (2023)
Attributed to:
New non-paralytic botulinum molecules for the control of pain
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202201631
PubMed Identifier: 37041008
Publication URI: http://europepmc.org/abstract/MED/37041008
Type: Journal Article/Review
Volume: 6
Parent Publication: Life science alliance
Issue: 6
ISSN: 2575-1077